Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07020234 · ClinicalTrials.gov registry record · NA
National Survey to Understand Ethical, Legal and Social Issues in Communicating to the Public About Epigenetics
A NA study, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- NA
- Development phase
- 2,040
- Enrollment target
NCT07020234: Completed NA study, sponsored by Washington University School of Medicine.
NCT07020234 is a NA study that has completed, run by Washington University School of Medicine. The registered enrollment target is 2,040 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (45% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07020234, a NA study, has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 2,040 participants
- Enrollment target
Study Summary
Few people realize that environmental pollution and some behaviors like physical activity and tobacco smoking can affect their health by "turning on" or "turning off" certain genes through a process called "epigenetic modification." This study will develop and test strategies for communicating about epigenetics that are understandable and that increase acceptance of using epigenetics in clinical settings.
Primary Outcome
We will measure this outcome using a sum score of correct answers for 8 individual items.
Interventions
- BEHAVIORAL Epigenetics Video
- BEHAVIORAL Nanotechnology Video
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,040 participants |
| Start Date | 2025-06-12 |
| Est. Completion | 2025-07-18 |
| Phase | NA |
What the finished NCT07020234 record still lists
NCT07020234 is an interventional study that assigns participants to a tested intervention. Its 2,040 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (45% higher).
The record links to 0 conditions, and to 2 interventions - of which Epigenetics Video is the first listed.
NCT07020234 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07020234 about?
NCT07020234 is a clinical study titled "National Survey to Understand Ethical, Legal and Social Issues in Communicating to the Public About Epigenetics". Few people realize that environmental pollution and some behaviors like physical activity and tobacco smoking can affect their health by "turning on" or "turning off" certain genes through a process called "epigenetic modification." This study will develop and test strategies for communicating about...
What is the current status of trial NCT07020234?
This trial is currently completed. It is a NA study. The enrollment target is 2,040 participants. The study started on 2025-06-12. Estimated completion is 2025-07-18.
What interventions are being tested in trial NCT07020234?
The interventions under investigation include: Epigenetics Video (BEHAVIORAL), Nanotechnology Video (BEHAVIORAL).
Who is sponsoring clinical trial NCT07020234?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07020234's enrollment target sits among peer trials
2,040 52nd of 2000 higher than 1,949 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05138718 · 2,041 participants
FDG an Myocardial Infarction: The PIAF Trial
- NCT06825897 · 2,039 participants · NA
Delay AvoIding Primary Evaluation for ThRombectomy of Acute StrokE Patients With Large Vessel OCclusion in the Angiography SuiTe
- NCT06833476 · 2,044 participants
TTVR STRONG Under Coverage With Evidence Development (CED) Study
- NCT05625659 · 2,032 participants · NA
Comparison of Breast Cancer Screening With CESM to DBT in Women With Dense Breasts
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI